We describe recent changes in the College of American Pathologists Glycohemoglobin (gHb) Survey, made to improve the assessment of interlaboratory variability and the accuracy of results reported. The questionnaire portion of the survey was revised to include an updated listof current methods, and results for survey specimens were grouped according to the component measured (Hb A1, Hb A1, or total gHb). The survey specimen material was changed to a material thought to give more reliable results with all available methods. After these changes, instituted in 1989, between-laboratory CVs decreased for some methods. Furthermore, gHb values between method types were more consistent with results obtained from fresh blood samples under very controlled laboratory conditions. However, these recent data also show that the interlaboratory variability is still quite high for some methods and that the variability within and between method types is still very great. We describe a pilot standardization program for gHb measurement. The second category includes affinity chromatography, a technique that separates glib from nonglycated hemoglobin on the basis of the affinity of m-aminophenyl boromc acid for the cis-diol groups in the glucose portion of glib (8). Affinity chromatography separates not only Hb A1 but also other glycohemoglobins that cannot be separated by differences in their charge ("total glib"). Affinity chromatographic procedures involving disposable minicolujnns are widely used. Labile Schiff base intermediates generally do not interfere and are not removed (9).
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Glycohemoglobin
(glib) measurement is used widely in clinical practice to monitor long-term glycemia in persons with diabetes mellitus.4 glib, formed continuously in erythrocytes, is the product of a slow, nonenzymatic reaction between glucose and hemoglobin. Under most circumstances, glib measurement provides a reliable index of average blood glucose concentrations during the preceding two to three months (1) (2) (3) (4) (5) one-third measured Hb A1 by ion-exchange chromatography;
and one-third measured total glib by affinity chromatography.
The specific assays used for a representative survey performed in 1990 are shown in Table 1 . Table 2 lists some of the data from a representative CAP Survey in 1988, before any of the above changes were instituted.
For the purposes of this report, all results from participants using affinity chromography were classified under total gHb even though the 1988 survey did not use this classification. Between-laboratory CVs ranged from -9-18% for ion-exchange chromatographic methods measuring either Jib A1 or Hb A1,,, to -7-9% for affinity chromatographic methods measuring total gHb. Also as shown in Table 2 , the between-laboratory CVs decreased for some methods (1990 data, after changes in the survey). Interestingly, the CV for the Helena Glyco Hb Quik method (Helena results, we have developed recommendations to further improve interlaboratory comparisons.
Materials and Methods
Revision of CAP survey format: The format of the CAP gHb Survey was revised for the last survey of 1989 (1989 EC-D). The questionnaire, sent out quarterly with the survey specimen, is the form on which each laboratory records its method of analysis and results. This questionnaire was revised to include an updated list of methods currently used (based on previous survey responses). Methods were grouped according to the component measured (Jib A1, lb A1, and total gHb) and whether or not the labile fraction was removed (applicable to Jib A1 and Hb A1 methods only). This allowed participants to more easily provide accurate information about the methods they used; e.g., the previous questionnaire format did not include the option of"total glib" for affinity chromatography users. Survey results were summarized in a format similar to the questionnaire.
Change to a different quality-control (QC) material: In 1989, the survey material for proficiency testing in the CAP glib Survey was changed. The proficiency samples, prepared from diabetic and nondiabetic blood materials, are now obtained from Sherwood Medical (St. Louis, MO 63103). In 1990, the instructions for reconstitution of the QC material were revised so that the resulting hemolysate was comparable with hemoglobin concentrations in whole blood; thus, further dilution appropriate for each method could be accomplished easily. The addition of 250 L of distilled water to the material brings the concentration of hemoglobin to within the normal range for whole blood. Although these relationships are based on only three specific assay systems within one institution, the rela- Labs., Beaumont, TX 77704) had a large, unexplained increase after survey changes were made.
The dramatic decrease in CVs for the Diamat HPLC method is probably attributable to the change in survey material, as shown in the Diamat chromatograms (Figure 1) . Figure la, tionships should be approximated by most assay methods for properly stored samples. For example, a total glb (affinity) value of 19.5% should give an ion-exchange Hb A1 value of -15% and an lb A1,, value of 13% by the above equations; Survey results show mean values of 13.6% and 13.9% for the two most commonly used ion-exchange lb A1 methods and 12.6% and 9.9% for the most commonly used Jib A1,, methods. If results are grouped by method type (e.g., all ionexchange methods measuring lb A1), the first two 1990 gHb Surveys showed CVs ranging from 6.6% for all affinity chromatographic methods for a high-range control to 16.7% for all lb A1 electrophoresis methods for a low-range control (Table 3) .
Discussion
The diversity of glib methods currently in use, combined with the lack of available standards for use with many types of assays, makes it exceedingly difficult to compare results between laboratories. Results of methods currently available usually correlate well (13, 15) , even though they may measure different glb species (e.g., Jib A1 vs lb A1,, vs total glib).
A few commercially available methods do involve a calibration procedure. One method (Bio-Rad lb A1,, columns) includes three concentrations of calibrators in each assay; the calibrator values are assigned by that particular method. The Bio-Rad Diamat is calibrated with a single calibrator sample, with a value also assigned within-method.
A one-point within-method calibrator is also used in an affinity chromatography kit (Glycoscreen; Curtin Matheson Scientific, Inc., Houston, TX 77251). Most other commercially available methods do not include calibrators. Furthermore, there has been no attempt to provide calibrators that would be usable for more than one method type. Survey data with results of assay comparisons involving fresh wholeblood samples, our data suggest that the most recent survey data are more representative of results obtained for clinical use than were previous survey reports. In general, these recent data show that (a) a wide variety of methods are still being used to measure different glb species, (b) the interlaboratory variability is still quite large for certain methods, and (c) variability within method type (e.g., all lb A1,, methods) is also large for certain methods. Even methods from the same manufacturer that measure the same glib component do not always give the same absolute values, e.g., lb A1,, by Bio-Rad mini/microcolumns vs Diamat HPLC lb A1,, (lb A1 = 9.9% vs 12.6%, respectively, Table 2 ).
As early as 1985, the need for standardization of glib results was recognized by both the National Diabetes Data Group of the National Institutes of Health (4) and CAP (10). A recent report by Larsen et al. (17) showed that regular monitoring of glib in persons with diabetes can lead to improvement in glycemic control. Thus, we must recognize the usefulness of glib measurement in diabetes care and establish uniform care goals based on glib measurement.
We have reported previously the feasibility of interlaboratory standardization by use of a highly precise HPLC method (measuring lb A1,,) as a "reference" method, with hemolysate standards prepared from whole-blood samples (-70 #{176}C storage) (14). Standardized values obtained from an lb A1 minicolunm method and an affinity-chromatographic method were remarkably close to actual values measured by the "reference" method (14). Our four years of experience with this method of glib standardization, with affinity chroma-tography as the routine laboratory method, has shown excellent agreement in glib values. We have used both frozen hemolysate and lyophilized (Sherwood Medical) standards. In addition, interassay precision was significantly improved; over a 15-month period, the interassay CVs for standardized gHb values were 3.7% and 3.4% for low and high controls, respectively, compared with 7.5% and 6.3% for unstandardized results.
In our opinion, a first step toward large-scale standardization could be a pilot program that provides laboratories with lyophilized hemolysate "standards" (e.g., the same material as that currently used for the CAP Survey) at three concentrations of glib, with gHb values assigned by a well-accepted, highly precise method ("reference" method). At 
